Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

SHH protein helps nerve regeneration in hypertensive rats.

Finasteride increases CD8+ T cells in BPH tissues.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Anti-CD19 therapy may help treat SLE and NMOSD.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

5α-reductase inhibitors may lower the risk of death from bladder cancer.